NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM938896 Query DataSets for GSM938896
Status Public on Sep 20, 2013
Title Sample_GM12750_Directional_NT
Sample type SRA
 
Source name cultured B-cells
Organism Homo sapiens
Characteristics cell type: B-cells
cell line: GM12750
directional rnaseq: Directional
experiment: cDNAdirectional
treatment: non-targeting control siRNA
Biomaterial provider Coriell; http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&q=GM12750
Treatment protocol 5X105 cultured B cells were transfected with 2.5 nmol Accell siRNAs (Thermo Scientific) against ADAR1 and ADAR2 according to the manufacturer’s protocols. 2.5nmol of non-targeting control siRNA (NTC-siRNA) was transfected as negative controls. The transfected cells with siRNAs were incubated at 37°C in Accell transfection media for 96 hours. In time course experiment, cells were treated with another 2.5nmol of siRNAs 24 hours following the first treatment. Accell media was then replaced with regular growth media. Cells were allowed to recover for 24 hours before being harvested. For protein immunoprecipitation, Cells were lysed in Lysis buffer (20 mM Tris HCl (pH 8), 137 mM NaCl, 10% glycerol, 1% Nonidet P-40 (NP-40) and 2 mM EDTA) supplemented with 1XComplete protease inhibitors (Roche) and 1Xphosphatase inhibitors II and III (Sigma). Cell lysates containing 150 mg of total protein were incubated with 1 µg of anti-ADAR1 (#HPA003890, Sigma), or negative control rabbit IgG (ab46540, ABCAM) at 4°C overnight. Immuno-complex was pulled down using Protein A agarose (Roche), and washed 4 times with lysis buffer. Immunoprecipitate was eluted in 20 mM Tris/7.5, 150 mM NaCl, 2.5 mM MgCl2, 0.2% SDS at 30°C for 1 hour. Protein samples were analyzed by Western Blot using anti-ADAR antibody (1:1000) or anti-tubulin (1:2000, Millipore). For RNA-immunoprecipitation, anti-ADAR1 RNA-immunoprecipitation was carried out using Magna RNA-Binding Protein Immunoprecipitation Kit (Millipore) following manufacturer’s protocol. Briefly, for each immunoprecipitation reaction, 2X107 cultured B-cells were harvested and lysed in 100 µl of Lysis Buffer with protease and RNase inhibitors. 1 µg of anti-ADAR antibody (#HPA003890, Sigma) or negative control rabbit IgG (ab46540, ABCAM) were conjugated to magnetic Protein A/G beads. 100 µl of cell lysate was added into 900µl Immunoprecipitation Buffer with RNase inhibitor and incubated with cRNase inhibitor, and incubated with protease K in presence of 1%SDS at 55°C for 30 minutes. RNA was then extracted from supernatants using phenol:chloroform:isoamyl alcohol and precipitated using ethanol.
Growth protocol Cultured B-cell lines from two CEPH individuals (Centre d'Etude du Polymorphisme Humain), GM12004 and GM12750, were obtained from Coriell (Camden, NJ, USA). The B-cells were grown to a density of 5x105 cells/mL in RPMI 1640 supplemented with 15% fetal bovine serum, 100 units/mL penicillin and 100 μg/mL streptomycin, and 2 mmol/L L-glutamine. For downstream experiments, cells were harvested 24 hours after addition of fresh medium.
Extracted molecule total RNA
Extraction protocol RNA were extracted using Qiagen DNeasy blood and tissue kit and RNeasy Mini kit with DNase treatment, respectively (Qiagen). For transcriptome sequencing, total RNA was extracted using the RNeasy Mini kit with DNase treatment (Qiagen). RNA-seq libraries were prepared following Illumina TruSeq RNA sample preparation protocol or directional mRNA-Seq sample preparation protocol, respectively. The samples were sequenced using HiSeq 2000 instrument and 100-200 million 100-nt reads per sample were generated.
 
Library strategy RNA-Seq
Library source transcriptomic
Library selection cDNA
Instrument model Illumina HiSeq 2000
 
Data processing We have only FPKM gene expression analysis for 5 samples in current study. For other samples, we generated BAM files and utilized sequence information from the BAM files for studying RNA-editing and other types of single nucleotide differences. We also attached a spreadsheet on the Series record containing the sum of all RDDs determined for the combined analysis from the different individuals in this study.
Low quality bases at the 3' ends of reads defined by Illumina were trimmed, and the resulting reads were aligned to the human reference genome (hg18) using GSNAP (version 2011-03-28.v3) using the following parameters: Mismatches ≤[(read length+2)/12-2]; Mapping score ≥20; Soft-clipping on (-trim-mismatch-score=-3); Known exon-exon junctions (defined by RefSeq (downloaded March 7, 2011) and Gencode (version 3c)) and novel junctions (defined by GSNAP) were accepted. SNP sites in the CEU population from Hapmap (release #28) and 1000 Genomes (pilot project) were included for SNP-tolerant alignments. Only reads that aligned to one genomic location (uniquely mapped reads) were used in further analyses.
Expression levels of RNA transcripts were analyzed using Cufflinks.
Genome_build: HG18
 
Submission date May 29, 2012
Last update date May 15, 2019
Contact name Isabel Xiaorong Wang
Organization name HHMI/University of Michigan
Department Pediatrics&Genetics
Lab Dr. Vivian G. Cheung Lab
Street address 210 washtenaw ave
City Ann Arbor
State/province Michigan
ZIP/Postal code 48109
Country USA
 
Platform ID GPL11154
Series (1)
GSE38233 Study functions of ADAR proteins using next generation sequencing of genome and transcriptome
Relations
SRA SRX150771
BioSample SAMN01001227

Supplementary data files not provided
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap